Accuray Incorporated Market Cap ($17.68 Million)
Market Cap & Net Worth: Accuray Incorporated (ARAY)
Accuray Incorporated market cap. Accuray Incorporated (NASDAQ:ARAY) has a market capitalization of $17.68 Million ($17.68 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #25338 globally and #5374 in its home market, demonstrating a 13.85% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Accuray Incorporated's stock price $0.15 by its total outstanding shares 119439307 (119.44 Million). Also see Accuray Incorporated cash flow conversion for how efficiently the company converts equity into cash flow.
Accuray Incorporated Market Cap History (2015–2026)
Accuray Incorporated market cap history from 2015 to 2026. Data shows change from $806.22 Million to $17.68 Million (-27.86% CAGR). Check Accuray Incorporated (ARAY) stock price for real-time trading data and today's change.
Index Memberships
Accuray Incorporated is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.60 Trillion | 0.00% | #706 of 976 |
|
NASDAQ Composite
IXIC
|
$39.84 Trillion | 0.00% | #2324 of 3165 |
Weight: Accuray Incorporated's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Accuray Incorporated Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Accuray Incorporated's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore ARAY net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.04x
Accuray Incorporated's market cap is 0.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $513.59 Million | $383.41 Million | -$29.58 Million | 1.34x | N/A |
| 2018 | $407.29 Million | $404.90 Million | -$23.90 Million | 1.01x | N/A |
| 2019 | $336.82 Million | $418.79 Million | -$16.43 Million | 0.80x | N/A |
| 2020 | $498.06 Million | $382.93 Million | $3.83 Million | 1.30x | 130.14x |
| 2021 | $569.73 Million | $396.29 Million | -$6.31 Million | 1.44x | N/A |
| 2022 | $249.63 Million | $429.91 Million | -$5.35 Million | 0.58x | N/A |
| 2023 | $338.01 Million | $447.61 Million | -$9.28 Million | 0.76x | N/A |
| 2024 | $236.49 Million | $446.55 Million | -$15.54 Million | 0.53x | N/A |
| 2025 | $98.49 Million | $458.50 Million | -$1.59 Million | 0.21x | N/A |
| 2026 | $17.68 Million | $401.95 Million | -$49.19 Million | 0.04x | N/A |
Competitor Companies of ARAY by Market Capitalization
Companies near Accuray Incorporated in the global market cap rankings as of November 4, 2026. Also see Accuray Incorporated asset portfolio for a full breakdown of the balance sheet.
Key companies related to Accuray Incorporated by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $191.55 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $117.68 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #227 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $191.55 Billion | $110.16 |
| #204 | Stryker Corporation | NYSE:SYK | $117.68 Billion | $306.81 |
| #227 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $99.29 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Accuray Incorporated (2015–2026)
Market capitalization of Accuray Incorporated from 2015 to today. Between 2015 and today, Accuray Incorporated's market cap moved from $806.22 Million to $ 17.68 Million, with a yearly change of -27.86%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $17.68 Million | -82.05% |
| 2025 | $98.49 Million | -58.35% |
| 2024 | $236.49 Million | -30.04% |
| 2023 | $338.01 Million | +35.41% |
| 2022 | $249.63 Million | -56.18% |
| 2021 | $569.73 Million | +14.39% |
| 2020 | $498.06 Million | +47.87% |
| 2019 | $336.82 Million | -17.30% |
| 2018 | $407.29 Million | -20.70% |
| 2017 | $513.59 Million | -6.52% |
| 2016 | $549.42 Million | -31.85% |
| 2015 | $806.22 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Accuray Incorporated was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $17.68 Million USD |
| MoneyControl | $17.68 Million USD |
| MarketWatch | $17.68 Million USD |
| marketcap.company | $17.68 Million USD |
| Reuters | $17.68 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Accuray Incorporated
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation t… Read more